Sarcopenic obesity is a condition where the dual health risks of sarcopenia and obesity coexist. This presentation will discuss the prevalence of sarcopenia, obesity and sarcopenic obesity in people with upper gastrointestinal and hepatobiliary cancers and the implications for treatment outcomes. Opportunities to improve practice will be explored.